Author:
Negrini Cristina,Daniele F.,Mancuso M. E.,Rivolta G. F.,Tagliaferri A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy
Reference45 articles.
1. Prevention and control of haemophilia: memorandum from a joint WHO/WFH meeting. Bull World Health Organ 1991; 69(1): 17–26
2. Miners AH, Sabin CA, Stevens AJ, et al. Financing the rising cost of hemophilia care in a large comprehensive care centre. J R Coll Physicians Lond 1997; 31(6): 640–4
3. Linee guida per la terapia sostitutiva dell’emofilia e dei difetti ereditari della coagulazione. 2003. www.aiceonline.it accesso del 4 gennaio 2005
4. Mannucci PM, Schimpf K, Brettler DB, et al. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. Ann Intern Med 1990: 113(1): 27–32
5. Azzi A, Ciappi S, Morfini M, et al. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrates. Am J Hematol 1992: 39(3): 228–30
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献